Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1164.0 | 41 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 51.0 | 47 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1539.0 | 42 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1465.0 | 49 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1553.0 | 59 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 759.5 | 52 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 2180.0 | 49 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1633.0 | 68 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | VEGF | 881.5 | 62 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | VEGF | 1402.0 | 59 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | VEGF | 856.0 | 73 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | VEGF | 1456.0 | 60 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | VEGF | 1000.0 | 51 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | VEGF | 1366.5 | 46 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | VEGF | 1250.0 | 56 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | VEGF | 825.0 | 54 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | VEGF | 674.5 | 48 | ||||
RA1869 | 1 | VEGF | 27.0 | 49 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | VEGF | 1343.5 | 38 | ||||
N2759 | 1 | VEGF | 1192.0 | 24 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | VEGF | 1687.5 | 54 | ||||
RA1931 | 1 | VEGF | 715.5 | 38 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | VEGF | 1768.0 | 53 | ||||
N2586 | 1 | VEGF | 996.0 | 81 | |||||||
0 | VEGF | 48.0 | 71 |